Press Releases

Long-acting and Tumor Targeting MDNA109 Variants Dramatically Improve T-cell Stimulation, Tumor Control and Long Term Memory Response TORONTO, Sept. 26, 2019 /PRNewswire/ - Medicenna Therapeutics Corp.  ("Medicenna" or "the Company") (TSX: MDNA, OTCQB: MDNAF), a clinical stage immuno-oncology company dev

STOCKHOLM, Sept. 26, 2019 /PRNewswire/ -- Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that the last patient has been included in the OP-106 HORIZON pivotal phase 2 clinical study evaluating melflufen with dexamethasone in patients with relapsed/refractory multiple myeloma (RRMM). Oncopeptides has previously communicated a target enrollment of 150 patients

LAGUNA HILLS, Calif., Sept. 26, 2019 /PRNewswire/ -- Today, Medterra CBD announced it will become the exclusive CBD brand of

NEW YORK, Sept. 26, 2019 /PRNewswire/ -- New York City Economic Development Corporation (NYCEDC) and Deerfield Management, a New York City-based healthcare investment firm, announced a new partnership to redevelop a 12-story building located at 345 Park Avenue South into a life sciences campus as part of

Multi-State, Vertically Integrated National Cannabis Company Announces Industry's First National Program Dedicated to Training Formerly Incarcerated Prisoners for New Employment Opportunities PHOENIX, Sept. 26, 2019 /PRNewswire/ -- 

SUGAR LAND, Texas, Sept. 26, 2019 /PRNewswire/ -- QuVa Pharma, Inc. today announced it is completing the next phase of capacity expansion at its Bloomsbury, New Jersey, state-of-the-art cGMP compliant 503B FDA registered manufacturing facility.  The investment in post compounding and distribution ar

MENLO PARK, Calif., Sept. 26, 2019 /PRNewswire/ --

WAYLAND, Mass., Sept. 26, 2019 /PRNewswire/ -- Candela Corporation, a leading global medical aesthetic device company, announces today the Profound® treatment's launch of the "Bring the Snap Back" campaign.  The campaign includes an educational microsite and a contest to give consumers the chance to bring the snap back to their aging

BEDFORD, Mass., Sept. 26, 2019 /PRNewswire/ -- Access Vascular, a medical device company developing the next generation of intravenous devices from novel biomaterials designed to minimize the risk of bloodstream infection, catheter thrombosis, and vein trauma, announced $6M in new funding from new and existing investors. With this new r

SAN FRANCISCO, Sept. 26, 2019 /PRNewswire/ -- Nurx, the health tech company focused on sensitive health needs and the leading online provider for contraception, today announced a partnership with